Melinta Therapeutics

Patent cliffs & loss of exclusivity

Small Molecule Discovery

Company

AngelList URLhttps://angel.co/melinta-therapeutics-1
Company Operating StatusAcquired
Crunchbase URLhttps://www.crunchbase.com/organization/melinta
Facebook URLhttps://www.facebook.com/pages/Melinta%20Therapeutics/602034319900331/
Full Address44 Whippany Rd, Suite 280, Morristown, New Jersey 07960, US
LinkedIn URLhttps://www.linkedin.com/company/melinta-therapeutics/
Public/PrivatePrivate
Seedtable URLhttps://seedtable.com/companies/melinta-therapeutics

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. KIMYRSAORITAVANCIN DIPHOSPHATESmall mol.Jul 2035
  2. ORBACTIVORITAVANCIN DIPHOSPHATESmall mol.Jul 2035

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.